BSEBoard Meeting30 Sept 2026 · 30 Sept 2026, 08:46 pm

Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 along with the Limited Review Report of the Auditors thereon

Indegene Ltd · 544172

✦ AI SummaryResults

Indegene Ltd has scheduled a Board Meeting on 29/10/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 along with the Limited Review Report of the Auditors thereon.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indegene Ltd - 544172 - Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026 Along With The Limited Review Report Of The Auditors Thereon.

Attachments (1)

📄

ad24fbb1-e6b1-48e4-a3a5-648c50901344.pdf

pdf

Download →
View document text
INDGN/SE/2026-27/55 30 September 2026 BSE Limited, National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai- 400001, India. Mumbai – 400 051, India. Scrip Code: 544172 Trading symbol: INDGN Dear Sir / Madam, Subject: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 29 of the SEBI Listing Regulations, we hereby inform you that the meeting of the Board of Directors of Indegene Limited is scheduled to be held on Thursday, 29 October 2026, to consider and approve: 1. The unaudited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter and half year ended 30 September 2026 along with the limited review report of the Auditors thereon. 2. The unaudited standalone financial results of the Company as per INDAS for the quarter and half year ended 30 September 2026 along with the limited review report of the Auditors thereon. 3. Allotment under RSU Scheme 2020 and ESOP Scheme 2020 In accordance with SEBI (Prohibition of insider Trading) Regulation, 2015 the trading window for trading in securities of the Company is closed from 01 October 2026 and shall open 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended 30 September, 2026. The above information will be made available on the website of the Company: https://www.indegene.com/ We request you to kindly take the same on record. Thanking You Yours Sincerely, For Indegene Limited Srishti Ramesh Kaushik Company Secretary and Compliance Officer Encl: A/a Indegene Limited Third Floor, Aspen G-4 Block, Manyata Embassy Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru- 560 045, Karnataka, India Phone: +91 80 4674 4567, +91 80 4644 7777 compliance.officer@indegene.com www.indegene.com CIN: L73100KA1998PLC102040